1,194
Views
13
CrossRef citations to date
0
Altmetric
Mini Review

Molecular mechanisms linking geranylgeranyl diphosphate synthase to cell survival and proliferation

, &
Pages 1-11 | Received 03 Feb 2016, Accepted 29 Jun 2016, Published online: 18 Aug 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Annalisa Marcuzzi, Elisa Piscianz, Liza Vecchi Brumatti & Alberto Tommasini. (2017) Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes. Expert Opinion on Orphan Drugs 5:6, pages 515-524.
Read now

Articles from other publishers (12)

Molly E. Muehlebach & Sarah A. Holstein. (2023) Geranylgeranyl diphosphate synthase: Role in human health, disease and potential therapeutic target. Clinical and Translational Medicine 13:1.
Crossref
Liping ZhuFangbo LiuQiang HaoTian FengZeshuai ChenShengquan LuoRui XiaoMengxiang SunTing ZhangXiaohang FanXianqin ZengJianguo HePing YuanJinming LiuMatthieu RuizJocelyn Dupuis & Qinghua Hu. (2021) Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension. Circulation 143:18, pages 1775-1792.
Crossref
Gökçen Boran, Sepideh Tavakoli, Ingo Dierking, Ali Reza Kamali & Duygu Ege. (2020) Synergistic effect of graphene oxide and zoledronic acid for osteoporosis and cancer treatment. Scientific Reports 10:1.
Crossref
Nazmul H. Bhuiyan, Michelle L. Varney, Deep S. Bhattacharya, William M. Payne, Aaron M. Mohs, Sarah A. Holstein & David F. Wiemer. (2019) ω-Hydroxy isoprenoid bisphosphonates as linkable GGDPS inhibitors. Bioorganic & Medicinal Chemistry Letters 29:19, pages 126633.
Crossref
Sherry S. Agabiti, Jin Li, Willie Dong, Michael M. Poe & Andrew J. Wiemer. (2019) Regulation of the Notch-ATM-abl axis by geranylgeranyl diphosphate synthase inhibition. Cell Death & Disease 10:10.
Crossref
Staci L. Haney, Yashpal S. Chhonker, Michelle L. Varney, Geoffrey Talmon, Daryl J. Murry & Sarah A. Holstein. (2018) Preclinical investigation of a potent geranylgeranyl diphosphate synthase inhibitor. Investigational New Drugs 36:5, pages 810-818.
Crossref
Yashpal S. Chhonker, Staci L. Haney, Robert A. Matthiesen, David F. Wiemer, Sarah A. Holstein & Daryl J. Murry. (2018) Quantitative determination of a potent geranylgeranyl diphosphate synthase inhibitor using LC–MS/MS: Derivatization and application. Journal of Pharmaceutical and Biomedical Analysis 153, pages 22-28.
Crossref
Łukasz Joachimiak, Aleksandra Marchwicka, Edyta Gendaszewska-Darmach & Katarzyna M. Błażewska. (2018) Synthesis and Biological Evaluation of Imidazole-Bearing α-Phosphonocarboxylates as Inhibitors of Rab Geranylgeranyl Transferase (RGGT). ChemMedChem 13:8, pages 842-851.
Crossref
Robert A. Matthiesen, Michelle L. Varney, Pauline C. Xu, Alex S. Rier, David F. Wiemer & Sarah A. Holstein. (2018) α-Methylation enhances the potency of isoprenoid triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors. Bioorganic & Medicinal Chemistry 26:2, pages 376-385.
Crossref
Aleksandra Kaźmierczak, Damian Kusy, Sanna P. Niinivehmas, Joanna Gmach, Łukasz Joachimiak, Olli T. Pentikäinen, Edyta Gendaszewska-Darmach & Katarzyna M. Błażewska. (2017) Identification of the Privileged Position in the Imidazo[1,2- a ]pyridine Ring of Phosphonocarboxylates for Development of Rab Geranylgeranyl Transferase (RGGT) Inhibitors . Journal of Medicinal Chemistry 60:21, pages 8781-8800.
Crossref
Staci Haney, Veronica Wills, David Wiemer & Sarah Holstein. (2017) Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors. Molecules 22:6, pages 886.
Crossref
Sherry S Agabiti, Jin Li & Andrew J Wiemer. (2017) Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation. Cell Death & Disease 8:3, pages e2678-e2678.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.